Journal of Medical Case Reports
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
Case reportDiverse histologic appearances in pulmonary mucinous cystic neoplasia: A case reportChristine Wynveen1 , Behnaz Behmaram2 , George Haasler3 and Nagarjun Rao2  1
Department of Pathology, Memorial Sloane Kettering Cancer Center, New York, NY, USA 2
Departments of Pathology Medical College of Wisconsin, Milwaukee, W. Wisconsin Avenue, WI 53226, USA 3
Thoracic Surgery, Medical College of Wisconsin, Milwaukee, W. Wisconsin Avenue, WI 53226, USA author email corresponding author email
Journal of Medical Case Reports 2008,
2:312doi:10.1186/1752-1947-2-312
|
| Published: |
29 September 2008 |
Abstract
Introduction
Primary pulmonary mucinous cystic neoplasia comprises a group of tumors, from benign cystadenoma to mucinous cystadenocarcinoma.
Case presentation
We report a case of primary pulmonary mucinous cystadenocarcinoma in a 75-year-old woman who was found to have a right hilar mass on a routine chest X-ray. A lobectomy was performed and the resection specimen revealed a multicystic mucinous tumor. Microscopically, the tumor was composed of confluent mucin-filled cystic spaces lined by columnar mucin-secreting cells which ranged from cytologically bland to moderately atypical with 'bronchioloalveolar pattern' invasion into the adjacent parenchyma. Immunohistochemically, tumor cells were positive diffusely for Cytokeratin 7, and focally for Cytokeratin 20 and Thyroid Transcription Factor-1.
Conclusion
This case highlights the continuous spectrum of pulmonary mucinous cystic neoplasia from benign mucinous cystadenoma to malignant mucinous cystadenocarcinoma, and the probable existence of a 'borderline' mucinous cystic tumor. Although molecular data are lacking to substantiate progression from benign to malignant in these neoplasms, the importance of recognizing the morphologic continuum lies in alerting pathologists to thoroughly examine specimens to rule out invasive foci in tumors with 'borderline' morphology. |